⌘K
Loading ticker…
As of 2026-08-24, LB Pharmaceuticals Inc Common Stock (LBRX) has a 3-month relative strength percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.1%, relative volume 0.66×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
LBRX is held by 15 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $3M notional. Top 3 carry $6M.
Held by 28 ETFs · $51M across latest filings · largest weight 0.71% (XPH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $3M | — |
| VTWO | 0.02% | $3M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $351K | — |
| AVSC | 0.01% | $325K | new |
| VTWG | 0.02% | $267K | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.02% |
| $209K |
| — |
| OMFS | 0.04% | $103K | new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $46K | — |
| ITWO | 0.01% | $25K | — |
| URTY | 0.01% | $20K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Not enough history to compute monthly seasonality for LBRX.